Public Joint-Stock Company "Pharmsynthez" (LIFE.ME)
RUB 3.26
(-0.15%)
RUB 3.26
(-0.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -167.48 Million RUB | 19.38% |
| 2021 | -169.13 Million RUB | -308.44% |
| 2020 | -41.41 Million RUB | 94.32% |
| 2019 | -729.14 Million RUB | -1193.07% |
| 2018 | 66.7 Million RUB | 102.32% |
| 2017 | -2.87 Billion RUB | -366.91% |
| 2016 | -616.09 Million RUB | -2.65% |
| 2015 | -600.17 Million RUB | -188.13% |
| 2014 | -208.29 Million RUB | -15.92% |
| 2013 | -179.69 Million RUB | 0.0% |
| 2011 | 3 Million RUB | -92.85% |
| 2010 | 41.95 Million RUB | 155.98% |
| 2009 | 16.38 Million RUB | -21.77% |
| 2008 | 20.95 Million RUB | -35.22% |
| 2007 | 32.34 Million RUB | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -23.31 Million RUB | 0.0% |
| 2023 Q1 | -23.31 Million RUB | 30.92% |
| 2022 Q4 | -33.75 Million RUB | 0.0% |
| 2022 Q1 | -27.19 Million RUB | 76.34% |
| 2022 FY | -136.35 Million RUB | 19.38% |
| 2022 Q2 | -65.4 Million RUB | -140.49% |
| 2022 Q3 | -33.75 Million RUB | 48.39% |
| 2021 FY | -169.13 Million RUB | -308.44% |
| 2021 Q2 | -213 Million RUB | -58.27% |
| 2021 Q3 | 20.8 Million RUB | 109.77% |
| 2021 Q4 | -114.94 Million RUB | -652.38% |
| 2021 Q1 | -134.58 Million RUB | -65.09% |
| 2020 Q4 | -81.52 Million RUB | -373.9% |
| 2020 Q1 | -56.47 Million RUB | 20.64% |
| 2020 FY | -41.41 Million RUB | 94.32% |
| 2020 Q2 | -61.53 Million RUB | -8.96% |
| 2020 Q3 | -17.2 Million RUB | 72.05% |
| 2019 Q1 | -28.79 Million RUB | -196.17% |
| 2019 Q3 | -80.06 Million RUB | 5.5% |
| 2019 Q4 | -71.16 Million RUB | 11.12% |
| 2019 FY | -729.14 Million RUB | -1193.07% |
| 2019 Q2 | -84.73 Million RUB | -194.25% |
| 2018 Q3 | 29.94 Million RUB | 124.26% |
| 2018 Q2 | -123.44 Million RUB | 0.0% |
| 2018 Q1 | -123.44 Million RUB | 54.9% |
| 2018 FY | 66.7 Million RUB | 102.32% |
| 2018 Q4 | 29.94 Million RUB | 0.0% |
| 2017 Q3 | -273.72 Million RUB | -17.02% |
| 2017 FY | -2.87 Billion RUB | -366.91% |
| 2017 Q1 | -233.9 Million RUB | 64.35% |
| 2017 Q4 | -273.72 Million RUB | 0.0% |
| 2017 Q2 | -233.9 Million RUB | 0.0% |
| 2016 Q4 | -656.06 Million RUB | 0.0% |
| 2016 Q3 | -656.06 Million RUB | -280.39% |
| 2016 FY | -616.09 Million RUB | -2.65% |
| 2016 Q1 | 363.68 Million RUB | 370.95% |
| 2016 Q2 | 363.68 Million RUB | 0.0% |
| 2015 Q3 | -134.22 Million RUB | 4.47% |
| 2015 FY | -600.17 Million RUB | -188.13% |
| 2015 Q1 | -140.5 Million RUB | -38.36% |
| 2015 Q4 | -134.22 Million RUB | 0.0% |
| 2015 Q2 | -140.5 Million RUB | 0.0% |
| 2014 Q1 | -17.25 Million RUB | 74.66% |
| 2014 Q4 | -101.54 Million RUB | 0.0% |
| 2014 FY | -208.29 Million RUB | -15.92% |
| 2014 Q3 | -101.54 Million RUB | -127.65% |
| 2014 Q2 | -44.6 Million RUB | -158.52% |
| 2013 Q2 | -29.49 Million RUB | -60.38% |
| 2013 Q3 | -68.09 Million RUB | -130.9% |
| 2013 Q4 | -68.09 Million RUB | 0.0% |
| 2013 Q1 | -18.38 Million RUB | 0.0% |
| 2013 FY | -179.69 Million RUB | 0.0% |
| 2011 FY | 3 Million RUB | -92.85% |
| 2010 FY | 41.95 Million RUB | 155.98% |
| 2009 FY | 16.38 Million RUB | -21.77% |
| 2008 FY | 20.95 Million RUB | -35.22% |
| 2007 FY | 32.34 Million RUB | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|